Showing results (961-970 of 6,500) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|June 17, 2010
Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?Stanisław Szala, Iwona Mitrus, Aleksander SochanikCancer Immunology, Immunotherapy : CII|August 30, 2011
Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapyRieneke van de Ven, Anneke W Reurs, Pepijn G J T B Wijnands, et al.Cancer Immunology, Immunotherapy : CII|September 9, 2011
Role of CD44 in lymphokine-activated killer cell-mediated killing of melanomaJingping Sun, Gabriela P Law, Robert J McKallipCancer Immunology, Immunotherapy : CII|September 21, 2011
Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditionsToshitatsu Ogino, Hideya Onishi, Hiroyuki Suzuki, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Relationship between general or specific immunoreactivity and prognosis in postoperative patients with hepatocellular carcinomaH Yamasaki, E Okamoto, T Komatsu, et al.Cancer Immunology, Immunotherapy : CII|December 24, 2011
Animal models for IgE-meditated cancer immunotherapyTracy R Daniels, Otoniel Martínez-Maza, Manuel L PenichetCancer Immunology, Immunotherapy : CII|December 24, 2011
Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cellsHelen Conroy, Karen C Galvin, Sarah C Higgins, et al.Cancer Immunology, Immunotherapy : CII|December 24, 2011
The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cuesJurjen Tel, Stanleyson V Hato, Ruurd Torensma, et al.Cancer Immunology, Immunotherapy : CII|February 3, 2012
The entirely carbohydrate immunogen Tn-PS A1 induces a cancer cell selective immune response and cytokine IL-17Ravindra A De Silva, Dananjaya K Appulage, Halina Pietraszkiewicz, et al.Cancer Immunology, Immunotherapy : CII|January 25, 2012
IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patientsB Schilling, E S Halstead, P Schuler, et al.Pageof 650